Modulate Bio is developing next-gen GABA-A positive allosteric modulators to treat neurological disorders, including Essential Tremor, epilepsy and anxiety, without the sedative effects associated with benzodiazepines and neurosteroids.
| Website | https://modulatebio.com |
| Employees | 4 (3 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Neurological Disorders Treatment, Epilepsy Treatment, Anxiety Treatment, Next Generation Therapeutics, Drug Development, Pharmaceutical Research, Therapeutic Drug Development, Nervous System, Novel Therapeutics, Biotechnology, Clinical Development |
Looking for a particular Modulate Bio employee's phone or email?
Modulate Bio Questions
Andrew Thomson is the CEO + Co-founder of Modulate Bio.
3 people are employed at Modulate Bio.
Modulate Bio is based in Cambridge, Massachusetts.
Top Modulate Bio Employees
-
Andrew Thomson
CEO + Co-founder at Modulate Bio
Boston, MA, US21 -
Kevin Hodgetts
Co-Founder at Modulate Bio
Boston, MA, US45+ -
Dario Doller
Chief Scientific Officer (CSO) at Modulate Bio
New York, NY, US33
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups.
Search the #1
Contact Database
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Use our
AI-Powered
Email Finder
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.
G2Crowd Trusted
300K+
Plugin Users
